ROSE LifeScience Adds HEXO’s Québec Portfolio for Commercialization and Distribution Services
2023年5月2日 - 8:00PM
ROSE LifeScience Inc. (“ROSE”), a Québec-based cannabis
producer, distributor, and marketer, today announced that it will
add HEXO Corp.’s (“HEXO”) Québec portfolio to ROSE’s industry
leading commercialization and distribution services business.
Headquartered in Gatineau, Québec, HEXO delivers premium
cannabis experiences that inspire customer loyalty, from
recreational to therapeutic products. HEXO’s products balance THC
with CBD, terpene levels and flavonoids, to create high-quality,
clean, consistent customer favourites. HEXO’s state-of-the-art
facilities in Masson-Angers, Québec are purpose-built and
engineered to provide exceptional capacity and streamlined
operations, developing innovative products to serve the cannabis
market in Québec, across Canada and globally.
ROSE’s commercialization and distribution expertise will help to
position HEXO’s Québec portfolio for further expansion in the
province, complementing ROSE’s relationship with Tilray Brands,
Inc. (“Tilray”), a long-standing ROSE commercialization and
distribution partner.
“This exclusive partnership further demonstrates ROSE’s status
as a trusted Québec company serving the Québec consumer,” said
Davide Zaffino, President and CEO, ROSE
LifeScience Inc.
“ROSE’s commercialization and distribution services business has
seen great success since its inception in 2019, enabling carefully
selected partners to grow their presence and portfolio in Québec.
We welcome HEXO to our portfolio of partnerships which, in addition
to our exclusive partnership with Tilray, includes Entourage Health
Corp., The Flowr Corporation, HYTN, Cann Social Tonic, Final Bell
and numerous Québec-based craft suppliers,” added
Zaffino.
“As an organization with deep roots in Québec, it’s important
that HEXO’s portfolio continues to be managed locally, to best
respond to Québecers’ needs,” said Charlie Bowman,
President and CEO, HEXO. “Adding the expertise of the ROSE team
will strengthen our Québec presence and enhance our distribution
within the province.”
About ROSE LifeScience Inc.ROSE LifeScience is
committed to ensuring that consumers benefit from the responsible
production, sale, and consumption of cannabis in Québec and across
Canada. From cannabis cultivation to marketing, commercialization,
and logistics, the Huntingdon, QC company plays a key
role in the Québec market. In addition to its own products and
expertise, ROSE provides specialized industry services to selected
producers to encourage a diversified offering in the Québec and
Canadian markets. Rose LifeScience is a majority-owned subsidiary
of Village Farms International (Nasdaq: VFF) with the balance owned
and operated by its Québec-based founders. For more
information, visit roselifescience.ca.
About HEXO Corp.
HEXO is an award-winning licensed producer of premium products
for the global cannabis market. HEXO delivers a thoughtfully
curated portfolio of both recreational and therapeutic cannabis
products that inspire customer loyalty. HEXO’s brands include HEXO,
Redecan, Original Stash, Bake Sale and T 2.0, as well as medical
cannabis products.
HEXO’s world-class Canadian grow sites are unmatched in size,
technological advantage and yield of high-quality cannabis, driving
innovation through every step of the process. HEXO operates three
major grow sites in Ontario and Québec, including one of the
largest grow facilities in North America. HEXO Corp. is a publicly
traded company under the tickers (TSX: HEXO) and (NASDAQ:HEXO).
For media inquiries, please contact:Valentine VaillantChief
Commercial
Officervalentine.vaillant@roselifescience.ca438 989-6654
HEXO (TSX:HEXO)
過去 株価チャート
から 10 2024 まで 11 2024
HEXO (TSX:HEXO)
過去 株価チャート
から 11 2023 まで 11 2024